Cargando…
Molecular Analysis of katG Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis
Isoniazid (INH) is a drug for the treatment of tuberculosis in patients infected with Mycobacterium tuberculosis. The katG enzyme, or catalase-peroxidase, activates the pro-drug INH that is coded by the katG gene in M. tuberculosis. Mutations of the katG gene in M. tuberculosis are a major INH resis...
Autores principales: | Purkan, P, Ihsanawati, I, Natalia, D, Syah, YM, Retnoningrum, DS, Siswanto, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101688/ https://www.ncbi.nlm.nih.gov/pubmed/30140323 |
Ejemplares similares
-
Intracellular targeting of ascomycetous catalase-peroxidases (KatG1s)
por: Zámocký, Marcel, et al.
Publicado: (2013) -
Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis
por: Munir, Asma, et al.
Publicado: (2021) -
Role of Mycobacterium avium catalase-peroxidase (KatG) in the pathogenesis of MAC disease in HIV patients
por: Latawa, Romica, et al.
Publicado: (2012) -
Two Novel katG Mutations Conferring Isoniazid Resistance in Mycobacterium tuberculosis
por: Hsu, Li-Yu, et al.
Publicado: (2020) -
Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis.
por: Shim, T. S., et al.
Publicado: (1997)